Etanercept

Two-year study of etanercept in pediatric patients with JIA, PsA shows …
A sustained response was observed in pediatric patients with juvenile idiopathic arthritis, enthesitis-related arthritis, psoriatic arthritis or extended oligoarthritis treated with etanercept over 96 weeks with no serious adverse events, according to ... [...]
2
Like
Save
BENEPALI®, the First Etanercept Biosimilar Referencing Enbrel®, Approved in …
BENEPALI has been granted marketing authorization in the European Union (EU) for the treatment of adults with moderate to severe rheumatoid arthritis (RA), psoriatic arthritis, non-radiographic axial spondyloarthritis and plaque psoriasis. Biogen ... [...]
5
Like
Save